| __timestamp | Amgen Inc. | Catalent, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4699000000 | 334800000 |
| Thursday, January 1, 2015 | 4846000000 | 337300000 |
| Friday, January 1, 2016 | 5062000000 | 358100000 |
| Sunday, January 1, 2017 | 4870000000 | 402600000 |
| Monday, January 1, 2018 | 5332000000 | 462600000 |
| Tuesday, January 1, 2019 | 5150000000 | 512000000 |
| Wednesday, January 1, 2020 | 5730000000 | 577900000 |
| Friday, January 1, 2021 | 5368000000 | 687000000 |
| Saturday, January 1, 2022 | 5414000000 | 844000000 |
| Sunday, January 1, 2023 | 6179000000 | 831000000 |
| Monday, January 1, 2024 | 7096000000 | 935000000 |
Cracking the code
In the world of pharmaceuticals and biotechnology, understanding spending patterns can reveal much about a company's strategic priorities. Amgen Inc. and Catalent, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, Amgen's Selling, General, and Administrative (SG&A) expenses have shown a steady increase, peaking at approximately $6.2 billion in 2023, marking a 31% rise from 2014. This growth reflects Amgen's expansive strategies and robust market presence.
Conversely, Catalent, Inc. has demonstrated a more dynamic growth trajectory. Starting at a modest $334 million in 2014, Catalent's SG&A expenses surged by 179% to reach $935 million in 2024. This rapid increase underscores Catalent's aggressive expansion and investment in operational capabilities. Notably, the data for Amgen in 2024 is missing, leaving room for speculation on its future financial strategies.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Amgen Inc.
Comparing SG&A Expenses: Pfizer Inc. vs Catalent, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Amgen Inc. and Vertex Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Amgen Inc. and Amneal Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and ImmunityBio, Inc.
Amgen Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Amgen Inc. and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Catalent, Inc.
Comparing SG&A Expenses: Neurocrine Biosciences, Inc. vs Catalent, Inc. Trends and Insights
Comparing SG&A Expenses: Catalent, Inc. vs ImmunityBio, Inc. Trends and Insights
Comparing SG&A Expenses: Catalent, Inc. vs Supernus Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Catalent, Inc. and BioCryst Pharmaceuticals, Inc.